Prevalence of AZ among Women in Modern Times Problem Statement Alzheimer's disease is a severe health issue that affects millions of people globally, and women are disproportionately affected by the disease. Despite being aware of this issue, there is a lack of comprehensive understanding of the prevalence and factors contributing to the development of Alzheimer's...
Prevalence of AZ among Women in Modern Times
Problem Statement
Alzheimer's disease is a severe health issue that affects millions of people globally, and women are disproportionately affected by the disease. Despite being aware of this issue, there is a lack of comprehensive understanding of the prevalence and factors contributing to the development of Alzheimer's disease among women in modern times.
The existing literature on Alzheimer's disease mainly focuses on general aspects of the disease, and little attention has been paid to understanding the gender differences in disease prevalence, risk factors, and treatment options (Ferretti et al., 2020). This gap in knowledge creates a significant challenge for healthcare professionals and policymakers to design effective prevention and treatment strategies for women at risk of Alzheimer's disease.
Therefore, there is a critical need to conduct research on this topic to provide a comprehensive understanding of the prevalence and factors contributing to the development of Alzheimer's disease among women (Toro et al., 2019).
The prevalence of Alzheimer's disease has increased in recent decades, likely due to factors such as increasing life expectancy, improved detection and diagnosis, and changes in lifestyle and environmental factors. A study conducted in the United States found that the prevalence of Alzheimer's disease increased by 89% between 2000 and 2017, with an estimated 5.8 million individuals aged 65 and older living with the disease in 2020, and reported deaths from Alzheimer’s increased 146.2% over the same time period (Alzheimer's Association, 2020).
Regarding gender differences, studies suggest that women have always been disproportionately affected by Alzheimer's disease compared to men (Belonwu et al., 2022). However, the exact extent of this disparity may have been underestimated in the past due to factors such as underdiagnosis and misdiagnosis. As awareness of Alzheimer's disease and its symptoms has increased, and more accurate diagnostic tools have become available, the gender disparity in the prevalence of Alzheimer's disease has become more apparent.
Moreover, research has shown that hormonal changes, genetics, and lifestyle factors all play a role, but the exact mechanisms are not yet fully understood (Zhu et al., 2021). Furthermore, while there have been studies on the prevalence of Alzheimer's disease in various populations, including women, there is still a lack of comprehensive understanding of the specific factors that contribute to the higher incidence of the disease in women. This is particularly true for women from minority populations, who may face additional barriers to accessing healthcare and may be underrepresented in research studies.
The lack of a comprehensive understanding of the prevalence and factors contributing to Alzheimer's disease among women is a significant issue because it limits the development of targeted interventions and prevention strategies. Without a clear understanding of the specific risk factors that affect women, healthcare providers may not be able to provide the most effective care or advice for women at risk of developing Alzheimer's disease. This may result in delayed diagnoses, missed opportunities for early intervention, and poorer outcomes for women with Alzheimer's disease.
This study aims to address this gap in knowledge by conducting a systematic review of relevant literature to identify the prevalence, risk factors, and treatment options for Alzheimer's disease among women. The results of this study will provide valuable insights into developing targeted interventions for women at risk of Alzheimer's disease, improving their quality of life and reducing the burden of the disease on society.
There are several reasons why the prevalence and factors contributing to the development of Alzheimer's disease among women must be studied. First, women are at higher risk of developing Alzheimer's disease than men, and this difference in risk is not fully understood. Therefore, understanding the underlying factors contributing to the higher prevalence of the disease in women is crucial for developing effective prevention and treatment strategies.
Second, Alzheimer's disease is a devastating illness that affects not only the individual but also their families and caregivers. The cost of caring for individuals with Alzheimer's disease is significant, both in terms of financial and emotional burden. Therefore, identifying risk factors and effective treatment options for Alzheimer's disease among women can help reduce the burden on families and caregivers and improve the quality of life for those affected.
Third, as the population continues to age, the number of individuals affected by Alzheimer's disease is expected to rise, and the burden of the disease will increase. Therefore, studying the prevalence and factors contributing to the development of Alzheimer's disease among women is critical to developing effective strategies to mitigate the impact of the disease on society.
Ultimately, studying the prevalence and factors contributing to the development of Alzheimer's disease among women is essential to developing effective prevention and treatment strategies, reducing the burden on families and caregivers, and mitigating the impact of the disease on society. But to get there it is essential that the rise in Alzheimer’s and its effects, including mortality in recent times, be better understood. If women are more susceptible to Alzheimer’s in modern times than they were in other times in history, health care providers need to know what is impacting them to put them more at risk today.
The remaining sections cover Conclusions. Subscribe for $1 to unlock the full paper, plus 130,000+ paper examples and the PaperDue AI writing assistant — all included.
Always verify citation format against your institution's current style guide.